ATMI LifeSciences And Artelis Sign Two Strategic Alliance Agreements
ATMI LifeSciences and Brussels-based Artelis today jointly announced agreements to focus on the commercialization and distribution of Artelis' proprietary disposable mixing technology integrated with ATMI's proprietary film technology, and to jointly develop, test, and manufacture single-use bioreactors/fermentors.
The agreements will leverage ATMI LifeSciences expertise in advanced ultra-clean film manufacturing and single-use mixing technology with Artelis' knowledge of the cell culture process, fermentation applications and disposable bioreactors to provide customers with higher performance in purity, precision and process efficiency in the manufacture of advanced biopharmaceuticals.
ATMI LifeSciences Managing Director, Mario Philips, said: "Our initial focus has been to establish our scalable contained powder and liquid single-use mixing technologies. Now, through our alliance with Artelis we are completing our single-use mixing product offering for scalable liquid-to-liquid mixing applications. Artelis' mixing technology is more advanced than the recirculation pump and magnetic mixer liquid-to-liquid mixing systems currently available in the marketplace. This enables us to have suitable mixing product offerings across all bioprocess applications for our customers."
"Signing such a commercial agreement with a multinational company like ATMI is a fantastic outcome for a one-year-old Belgian company and a significant achievement for the Artelis management team," said José Castillo, President of Artelis. "We have been able to demonstrate the unique competitive advantages of Artelis' mixing technology (patent pending) and our ability to execute on development and industrialization plans to deliver value to the biopharma industry. As both the founder of Artelis and a former executive of a large biopharma company, I am also pleased to share my vision of the future of this industry with a formidable player in the sector."
"I am also very excited about our Joint Development Agreement around disposable bioreactors and fermentors," added Philips. "The collaboration combines ATMI LifeSciences' expertise in vertically integrated ultra-clean film manufacturing and single-use mixing technology with Artelis' advanced process expertise in cell culture and fermentation applications. The jointly developed bioreactors and fermentors will be tested and validated within Artelis' new cell culture facility."
Hugues Bultot, CEO of Artelis said: "In addition to a worldwide Sales and Marketing agreement, ATMI offered Artelis a unique opportunity to leverage our process expertise in cell culture and fermentation applications with their own expertise in the development of advanced bioreactors, which we hope will be valued by our customers. This is the first international recognition for our "Contract Development Organization," an innovative Business Unit that offers development expertise in disposables for cell culture to others in the industry."
About Artelis
Known for its revolutionary products, Artelis develops disposable solutions for cell culture and provides the missing link to the plastic factory—the single-use bioreactor. For more information about Artelis, contact José Castillo at j.castillo@artelis.be or visit the company's Web site at www.artelis.be.
About ATMI LifeSciences
ATMI has recently established a product line under an ATMI LifeSciences banner focused on biopharmaceutical applications with flexible, film-based packaging products ranging from single-use mixing and storage vessels to ultraclean sterile containers. ATMI LifeSciences is a source of manufacturing efficiency to its biopharma customers, providing single-use smart processing and packaging technology solutions that maximize product integrity. Further information can be found at www.atmi-lifesciences.com.
ATMI provides specialty materials and high-purity materials handling and delivery solutions to the worldwide semiconductor industry. For more information, please visit www.atmi.com.
Source: ATMI LifeSciences